Lam Research Corporation Appoints Eric K. Brandt to Board of Directors

Lam Research Corporation (NASDAQ:LRCX) today announced that Eric K. Brandt has joined the Company’s board of directors.

"I am pleased to announce the appointment of Eric K. Brandt to the company’s board of directors,” stated James W. Bagley, executive chairman of Lam Research. "Eric’s wealth of management experience combined with his extensive financial and semiconductor industry experience offer a unique perspective that will be an asset to the board. We welcome Eric and look forward to the contributions he will make,” Bagley concluded.

Mr. Brandt is Executive Vice President and Chief Financial Officer of Broadcom Corporation, a position he has held since March 2007. From September 2005 through March 2007, Brandt served as President and Chief Executive Officer of Avanir Pharmaceuticals. Prior to joining Avanir, Mr. Brandt was Executive Vice President-Finance and Technical Operations and Chief Financial Officer of Allergan Inc., a global specialty pharmaceutical and medical device company, where he also held a number of other senior positions following his arrival there in 1999. Mr. Brandt previously spent ten years with The Boston Consulting Group, a privately-held global business consulting firm, most recently serving as Vice President and Partner.

Mr. Brandt currently serves as a member of the board of directors of Dentsply International, Inc., a public company. He has also served as a member of the boards of directors of Avanir and of Vertex Pharmaceuticals, Inc., where he served as chair of the Audit Committee, both public companies.

Mr. Brandt earned his Bachelor of Science Degree in Chemical Engineering from the Massachusetts Institute of Technology and Master of Business Administration Degree from the Harvard Business School.

Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world’s semiconductor industry. Lam’s common stock trades on The NASDAQ Global Select Market^SM under the symbol LRCX. Lam Research is a NASDAQ-100^® company. For more information, visit http://www.lamresearch.com/.